Cargando…
Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients
OBJECTIVE: The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients. BACKGROUND: Hepatocellular carcinoma (HCC) continues to be a serious disease burden. Interferon Induced Transmembrane protein 3 (IFITM3) is a protein that encoded in humans by the I...
Autores principales: | Bondok, Rania M., Barakat, Lamiaa A., Elsergany, Alyaa R., Mahsoub, Nancy, Ghattas, Maivel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290370/ https://www.ncbi.nlm.nih.gov/pubmed/37353775 http://dx.doi.org/10.1186/s12885-023-11071-2 |
Ejemplares similares
-
Interferon-Induced Transmembrane Protein 3 Expression Upregulation Is Involved in Progression of Hepatocellular Carcinoma
por: Hou, Yuli, et al.
Publicado: (2021) -
Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma
por: Hou, Yuli, et al.
Publicado: (2019) -
Evolution of vertebrate interferon inducible transmembrane proteins
por: Hickford, Danielle, et al.
Publicado: (2012) -
Interferon–Inducible Transmembrane Protein 3 (IFITM3) Restricts Rotavirus Infection
por: Pang, Zhaoxia, et al.
Publicado: (2022) -
Positive Regulation of the Antiviral Activity of Interferon-Induced Transmembrane Protein 3 by S-Palmitoylation
por: Wen, Shubo, et al.
Publicado: (2022)